Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-06

Clinical Trial Update: Effect of Early Administration of Albumin 20% Versus Crystalloid [NA]

View source ↗

Summary

This document reports an ongoing clinical trial comparing early administration of albumin 20% to crystalloid solutions in patients with septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin 20% (human albumin solution 20%)
  • Crystalloid solution (crystalloid IV fluids (e.g., normal saline or balanced crystalloids))

Snippet

Sponsor: Egymedicalpedia | Conditions: Septic Shock | NA | Status: RECRUITING